Positive results from early trial of drug that could protect brain cells
Date
News
Date
A small study shows that adaptive deep brain stimulation is better than the standard version at controlling movement symptoms day and night for people with Parkinson’s.
Date
We're investing £1.6m through our Virtual Biotech programme to drive forward the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s.
Date
In July, we had the pleasure of hosting Membership Matters, an online event exclusively for Parkinson's UK members. We were delighted to see over 200 members sign up to either join us live or watch the recording later.
Date
The To be Heard! music festival supported by Parkinson’s UK showcased the creativity and achievements of people living with young onset Parkinson’s.
Date
On 17 July, the King announced the new government's legislative programme for the next year. Here are the highlights and what it could mean for the Parkinson's community.
Date
We wanted to make sure as many newly elected MPs understand Parkinson’s and how they can support our work to improve health care and transport services and financial support.
Date
NHS Talking Therapies help people with their mental health. We want to hear about your experiences.
Date
It's not just MPs who have been busy campaigning. Our local campaigners have been hard at work too. Here are some highlights of our work in England since the start of 2024.
Date
The results found that Lee Silverman Voice Treatment (LSVT LOUD) is more effective than NHS speech and language therapy.
Date
We're providing £1.24m through our Virtual Biotech programme to help test a potential treatment called MTX325 in people with Parkinson’s.